Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dielectric levitation optical tweezers for powerful mesoscale biomanipulation.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Highly Efficient Capture of Sarcoma Cells in Microfluidic Devices.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Use of liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in neoadjuvant pancreatic adenocarcinoma: NEO-Nal-IRI trial.

The oncologist·2026
Same author

Biomolecular Condensates as Protein Degradation Tools for Intracellular Targets.

Nature communications·2026
Same author

Nano calligraphy via optical electro-aligning manipulation.

Microsystems & nanoengineering·2026
Same author

Development of a Platform for <i>in-situ</i> Airborne Virus Detection by Interfacing RT-LAMP Assay with a Condensational Growth Collector.

Aerosol science and technology : the journal of the American Association for Aerosol Research·2026

Related Experiment Video

Updated: Jul 24, 2025

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
05:58

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

1.3K

Microfluidics-Enabled Isolation and Single-Cell Analysis of Circulating Tumor Cells.

Minh-Chau N Le1, Kierstin A Smith1, Morteza Alipanah1

  • 1Interdisciplinary Microsystems Group, Department of Mechanical and Aerospace Engineering, University of Florida, Gainesville, FL, USA.

Methods in Molecular Biology (Clifton, N.J.)
|July 10, 2023
PubMed
Summary

Microfluidic devices can isolate and analyze circulating tumor cells (CTCs) from blood. This technology aids in cancer diagnosis, prognosis, and developing new cancer drugs by studying tumor characteristics.

Keywords:
Circulating tumor cellsMicrofluidicsProtein markersSarcomasSingle-cell analysis

More Related Videos

Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples
07:32

Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples

Published on: June 15, 2012

26.7K
Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
05:17

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment

Published on: May 14, 2019

8.7K

Related Experiment Videos

Last Updated: Jul 24, 2025

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
05:58

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

1.3K
Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples
07:32

Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples

Published on: June 15, 2012

26.7K
Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
05:17

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment

Published on: May 14, 2019

8.7K

Area of Science:

  • Oncology
  • Biotechnology
  • Medical Diagnostics

Background:

  • Circulating tumor cells (CTCs) are crucial biomarkers for cancer management.
  • Microfluidic platforms offer advanced tools for CTC isolation and analysis.
  • Understanding CTCs aids in cancer diagnosis, prognosis, and personalized treatment strategies.

Purpose of the Study:

  • To present protocols for fabricating and utilizing a microfluidic device for CTC analysis.
  • To demonstrate the application of microfluidics in enriching and detecting single CTCs.
  • To highlight the role of CTC analysis in cancer drug development and theranostics.

Main Methods:

  • Fabrication of a specialized microfluidic device.
  • Isolation and enrichment of CTCs from patient blood samples.
  • Detection and analysis of single CTCs using immunocytochemistry/immunofluorescence (ICC/IF) assays.

Main Results:

  • Successful enrichment and detection of single CTCs from sarcoma patient blood.
  • Demonstration of microfluidic platform's capability for CTC analysis.
  • Data generated can inform cancer diagnosis, prognosis, and treatment response prediction.

Conclusions:

  • Microfluidics combined with ICC/IF assays provide a powerful method for CTC analysis.
  • This approach facilitates the study of tumor heterogeneity and aids cancer drug development.
  • The developed microfluidic device offers a valuable tool for clinical applications in oncology.